Newsbenzinga
Argenx Says VYVGART Showed Continued Improvement In Ocular Myasthenia Gravis, Sustained One-Year Efficacy In Antibody-Negative Generalized MG
· Published
Article summary
Please check the source for details.
An excerpt from the original article.
Comments —
Loading comments…